Biosimilar Drugs for Multiple Sclerosis: An Unmet International Need or a Regulatory Risk? Posted on July 18, 2019 by Don MacDowall Rivera, Victor M Neurology and Therapy [Heidelberg] 01 July 2019 : pp.1-8 Formats: Citation/Abstract, Find It at Unimelb
